Rajiv Gandhi Cancer Institute & Research Centre

Rajiv Gandhi Cancer Institute & Research Centre Ethics. Empathy. Excellence. Delivering comprehensive cancer care trusted across India since 1996. 🎗

Since Inception in 1996, the institute has treated lacs of patients and will continually strive to treat and eliminate cancer, to provide an evidence-based high quality and focused approach to cancer care. We are responsive to the needs of patients and their families and as a part of an ongoing modernization program we are continually upgrading our services and equipments.

We are honoured to announce the Shri K. K. Mehta Memorial Oration at RGCON 2026, to be delivered by Prof. (Dr.) Atul Goe...
02/03/2026

We are honoured to announce the Shri K. K. Mehta Memorial Oration at RGCON 2026, to be delivered by Prof. (Dr.) Atul Goel, Head of the Department of Neuro-Surgery at Lilavati Hospital and Research Centre, Mumbai. Widely regarded as a thought leader in neurosurgery, Prof. Goel will present a compelling oration introducing a novel concept on how gliomas arise and grow along white fibres.

This prestigious session promises to offer a fresh scientific perspective, stimulate academic dialogue, and deepen our understanding of glioma biology with direct implications for surgical strategy and neuro-oncology practice. RGCON 2026 continues its tradition of celebrating excellence, innovation, and transformative thinking in brain and spine tumor care.

📅 15 March 2026 | ⏰ 11:00 – 11:45 AM
📍 New Delhi

The spirit of reflects the vital role of science in improving lives and strengthening healthcare systems for a healthi...
28/02/2026

The spirit of reflects the vital role of science in improving lives and strengthening healthcare systems for a healthier future.

Scientific progress continues to shape better care, deeper understanding, and improved outcomes for communities everywhere.

At , we remain committed to advancing healthcare through Ethics, Empathy & Excellence, guided by the principles of science and compassionate care.

The cannot rely on treatment alone, it must be compassionate enough to inspire hope. The recently concluded “जीव शरदः ...
28/02/2026

The cannot rely on treatment alone, it must be compassionate enough to inspire hope.

The recently concluded “जीव शरदः शतम्: Wishing Young Cancer Warriors – Health, Happiness, and Hope” at reflects our belief that cancer care is a true culmination of ethics, empathy, and excellence.

Together, we continue to stand beside every warrior — nurturing strength, celebrating survivorship, and building a future filled with hope.

27/02/2026

Recovery after cancer treatment requires not only medical follow-up, but also vigilant infection prevention and hygiene practices.

Dr. Neelam Sachdeva, Head - CSSD, Senior Consultant, Chief of Microbiology & Infection Control Officer, shares essential guidance on post-treatment care, especially for immunocompromised patients, including those recovering from lymphomas.

She highlights the importance of sanitization, preventing transmission of infection, and adopting safe hygiene practices to reduce complications and regain strength effectively.

At , we prioritize comprehensive cancer care that extends beyond treatment, ensuring every patient’s recovery journey is supported with strong infection control measures and expert guidance.

Together, we can create safer healing environments and empower patients to recover with confidence and care.

Introducing the Organising Committee behind RGCON 2026, the team steering this landmark international conference in neur...
27/02/2026

Introducing the Organising Committee behind RGCON 2026, the team steering this landmark international conference in neuro-oncology with vision, expertise, and commitment.

Led by Dr. I. C. Premsagar, Organising Chairman and Chief Neuro & Spine Oncology Services, RGCIRC, the conference is supported by an accomplished group of Organising Secretaries: Dr. Kaviraj Kaushik, Dr. Munish Gairola, and Dr. Rajat Saha each bringing deep clinical insight and leadership across surgical, radiation, and medical oncology.

Together, they are shaping RGCON 2026 as a powerful platform for collaboration, innovation, and excellence in brain and spine tumor care.
📍 New Delhi | 📅 13–15 March 2026
📌 Note: The first 50 delegates submitting abstracts will receive complimentary conference registration.

Oesophageal cancer often develops quietly, with symptoms that are easy to dismiss as routine digestive issues.When ident...
26/02/2026

Oesophageal cancer often develops quietly, with symptoms that are easy to dismiss as routine digestive issues.

When identified early, timely medical intervention can significantly improve treatment outcomes and quality of life.

At , patients receive care backed by advanced diagnostics, multidisciplinary expertise, and a philosophy rooted in ethics, empathy, and excellence.

Get screened today!

We are proud to announce the participation of Thomas E. Merchant, Chair of the Department of Radiation Oncology at St. J...
26/02/2026

We are proud to announce the participation of Thomas E. Merchant, Chair of the Department of Radiation Oncology at St. Jude Children’s Research Hospital, Memphis, at RGCON 2026. A global authority in pediatric radiation oncology, Dr. Merchant will contribute to key academic sessions spanning neuro-radiation oncology, pediatric neuro-oncology, and neuro-onco surgery.

His sessions will cover evidence-based practices in re-irradiation for pediatric brain tumours, the current state of CNS germ cell tumor management with insights from recent clinical trials, and contemporary concepts and dose considerations of proton therapy in gliomas. These discussions promise valuable clinical perspectives, trial-driven insights, and practical guidance for complex decision-making in neuro-oncology care. RGCON 2026 continues to bring together world-renowned experts to advance precision, innovation, and collaboration in multidisciplinary cancer management.

Dr. Munish Gairola is the Director – Radiation Oncology at RGCIRC, with over 30 years of experience in delivering advanc...
25/02/2026

Dr. Munish Gairola is the Director – Radiation Oncology at RGCIRC, with over 30 years of experience in delivering advanced radiation therapy across a wide spectrum of cancers.

He specializes in high-precision techniques for head & neck cancers, CNS malignancies, lung cancers, and paediatric cancers, using modalities such as IMRT, IGRT, adaptive radiotherapy, brachytherapy, SRT, SRS, SBRT, and SABR. He is also actively involved in academics, research, and teaching activities.

With a strong focus on precision, safety, and organ preservation, Dr. Gairola is committed to integrating cutting-edge radiation technologies to optimize outcomes while maintaining quality of life for patients at every stage of care.

We are proud to announce the participation of Prof. Dr. Sujit S. Prabhu, Professor, Department of Neurosurgery at UT MD ...
25/02/2026

We are proud to announce the participation of Prof. Dr. Sujit S. Prabhu, Professor, Department of Neurosurgery at UT MD Anderson Cancer Center and Adjunct Professor at Baylor College of Medicine, Houston, at RGCON 2026. An internationally respected leader in neuro-onco surgery, Prof. Dr. Prabhu will lead advanced workshops focused on functional preservation and cutting-edge preoperative technologies in glioma surgery.

His sessions will cover the fundamentals of intraoperative neuro-monitoring, including MEP, SEP, and cranial nerve monitoring with emphasis on troubleshooting and interpretation, as well as the role of preoperative technologies such as Transcranial Magnetic Stimulation (TMS) in predicting surgical outcomes in gliomas. These discussions will offer practical, evidence-based insights aimed at maximizing safe resection while preserving neurological function. RGCON 2026 continues to bring together global experts to advance precision, safety, and innovation in multidisciplinary neuro-oncology care.

We are proud to announce the participation of Dr. Sonika Dahiya, Professor of Pathology and Immunology at Washington Uni...
24/02/2026

We are proud to announce the participation of Dr. Sonika Dahiya, Professor of Pathology and Immunology at Washington University School of Medicine, St. Louis, USA, at RGCON 2026. A distinguished expert in neuropathology, Dr. Dahiya will lead multiple high-impact sessions focusing on redefining gliomas through key advances in WHO classification and their clinical implications.

She will also conduct a dedicated Neuropathology workshop offering deep insights into molecular risk parameters and WHO grading recommendations for meningiomas, along with a special session featuring a potpourri of interesting and challenging cases. These discussions will bridge pathology with clinical decision-making, strengthening precision-driven neuro-oncology care. RGCON 2026 continues to bring together global thought leaders to advance knowledge, collaboration, and excellence in multidisciplinary cancer management.

24/02/2026

Our immune system plays a critical role in protecting the body by identifying and eliminating abnormal cells before they turn harmful.

Dr. Varun Goel explains how cancer cells develop when these abnormal cells grow unchecked, and how advances like immunotherapy are helping the immune system recognize and fight growing cancer cells more effectively.

From lung and breast cancer to colon and uterine cancer, understanding this interaction between immunity and cancer is key to better outcomes.

At , we remain committed to spreading knowledge that supports timely diagnosis, informed treatment, and hope through innovation.

23/02/2026

The journey to effective cancer care begins with awareness, prevention, and the right treatment approach.

Dr. Kapil Goyal, Consultant – Medical Oncology at Rajiv Gandhi Cancer Institute & Research Centre, shares key insights on chemotherapy, immunotherapy, and advancements in treating conditions such as lymphomas.

He also highlights the role of early cancer screening, accurate diagnosis, and timely intervention in improving outcomes.

At , we emphasize not only advanced cancer treatment but also prevention, encouraging a no smoking, alcohol-free lifestyle, balanced diet, and proactive health checks to reduce risk and detect concerns early.

Together, we can empower individuals to make informed choices, prioritize screening, and take meaningful steps toward prevention and recovery.

Address

Rohini: D/18, Sector/5, Rohini, Delhi/, Niti Bagh: Mahendra Kumar Jain Marg, Niti Bagh, New Delhi/110049
Delhi
110085

Telephone

+91-11- 47022222

Website

Alerts

Be the first to know and let us send you an email when Rajiv Gandhi Cancer Institute & Research Centre posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Rajiv Gandhi Cancer Institute & Research Centre:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

Today, at Rajiv Gandhi Cancer Institute & Research Centre we are counted amongst Asia’s premier exclusive cancer centres that offer the unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighbouring SAARC countries and others.

We offer super specialised tertiary care services in Medical, Surgical and Radiation Oncology, streamlined into dedicated Site-Specific teams. Super Specialists at RGCIRC practice an organ specific multi-disciplinary approach to cancer diagnosis and treatment, with the Tumour Board acting as a second opinion clinic for cases that are more critical than others.

Spread over nearly 2 lakh square feet area, with a current capacity of 300 beds, outpatient services are spread on three floors with 57 consultation rooms, 27 bedded Surgical ICU and an 11 bedded Medical ICU.

Rajiv Gandhi Cancer Institute & Research Centre focuses on preventing and treating cancer by providing affordable oncology care of international standards in India.